Buy or sell Route 92 Medical stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Route 92 Medical Stock

Route 92 Medical is a medical device company developing a catheter to treat stroke.

About Route 92 Medical Stock

Route 92 Medical is a developer of a stealthy catheter for stroke treatment. The company was founded in 2015 and based in San Mateo, California.

Funding History

May 2016$5.9M
May 2017$5.9M
August 2018$4.7M
May 2019$13.0M
December 2021$56.0M
December 2021$55.0M


Sr. VP Clinical, Regulatory and Quality

Kirsten Valley

Board Member

Ariella Golomb

Chief Medical Officer and Co-Founder

Joey English

General Partner @ The Vertical Group

Jack W. Lasersohn

Board Observer

Robert Mittendorff

Founder and CEO

Tony M. Chou

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: